A Randomized Controlled Trial of Late Conversion from CNI‐Based to Sirolimus‐Based Immunosuppression Following Renal Transplantation
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (10) , 2496-2503
- https://doi.org/10.1111/j.1600-6143.2005.01055.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The effect of sirolimus on sex hormone levels of male renal transplant recipientsClinical Transplantation, 2005
- Late Calcineurin Inhibitor Withdrawal as a Strategy to Prevent Graft Loss in Patients with Suboptimal Kidney Transplant FunctionAmerican Journal of Nephrology, 2004
- Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-upTransplant International, 2002
- Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter StudyJournal of the American Society of Nephrology, 2002
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-ASSOCIATED NEPHROTOXICITYTransplantation, 1998
- CYCLOSPORIN CONVERSION VERSUS CONVENTIONAL IMMUNOSUPPRESSION: LONG-TERM FOLLOW-UP AND HISTOLOGICAL EVALUATIONThe Lancet, 1987
- CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCEThe Lancet, 1986
- A CONTROLLED TRIAL OF CYCLOSPORINE IN RENAL TRANSPLANTATION WITH CONVERSION TO AZATHIOPRINE AND PREDNISOLONE AFTER THREE MONTHSTransplantation, 1983
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979